FormlyAI is a regulatory services company powered by AI, supporting end-to-end certification across the US FDA, EU MDR, and other jurisdictions. Led by former FDA expert Dr. Spencer Todd, the team has delivered 80+ certifications across Class I–III and AI/SaMD, producing rigorous quality documentation and audit-ready submission packages designed to reduce review iterations and accelerate market entry.
As we look ahead to the 2026 program year, MedTech Innovator Asia Pacific continues to focus on building a strong, connected ecosystem to support emerging medical technology companies. Collaboration across industry, healthcare, and innovation partners remains central to helping founders navigate growth, commercialization, and real-world healthcare impact.
By bringing together diverse perspectives and expertise from across the healthcare ecosystem, we aim to create meaningful touchpoints to help innovators refine their strategies, build credibility, and better understand the realities of bringing medical technologies to market.
In 2026, MTI APAC looks forward to working closely with [Partner Name] as part of the program’s partner ecosystem. Together, we aim to support promising medical technology companies as they progress from innovation to real-world application, contributing to healthcare solutions that address genuine clinical and system-level needs across the region.